OOIR: Observatory of International Research

Papers

(The H4-Index of Future Medicinal Chemistry is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Identification of Sulfonamide-Based Butyrylcholinesterase Inhibitors Using Machine Learning	62
Investigations of New N ¹ -Substituted Pyrazoles as Anti-Inflammatory and Analgesic Agents having COX Inhibitory Act	55
The role of descriptors extracted from ligand-target interaction to improve conventional QSAR model performance in the realm of angiogenesis receptor modulation to fight cancer	51
Therapeutic N -Heterocyclic Carbenes: An Interview With Alejandro Bugarin	49
Targeting Tuberculosis – An Interview With Robert Abramovitch	40
The Connection Between PARP14 and SARS-CoV-2	40
Citrate Transporter Inhibitors: Possible New Anticancer Agents	40
Biological and computational evaluation of novel benzofuranyl derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors	32
Selection of SARS-CoV-2 Main Protease Inhibitor Using Structure-Based Virtual Screening	32
Super-Conserved Receptors Expressed in the Brain: Biology and Medicinal Chemistry Efforts	31
Development of 5-hydroxybenzothiophene derivatives as multi-kinase inhibitors with potential anti-cancer activity	30
Novel Set of Highly Substituted Bis-Pyridines: Synthesis, Molecular Docking and Drug-Resistant Antibacterial Profile	27
Design of SARS-CoV-2 Mpro, PLpro Dual-Target Inhibitors Based on Deep Reinforcement Learning and Virtual Screening	26
Combining Structure-Based and 3D QSAR Pharmacophore Models to Discover Diverse Ligands Against EGFR in Oral Cancer	25
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers	24
In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties	22
Combining EGFR Inhibitors With SHP2 Or LSD1 Inhibitors to Overcome Multidrug Resistance in Cancer	22
Advances in AR-Targeting Chimeras: A Case Study of proteolysis-targeting Chimeras From Bench to Bedside	21
Computational Insights Into Novel Inhibitor Indole-Heterocycle Specific Against Glycogen Phosphorylase Isoenzymes Interaction Mechanism	20
Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives	20
Discovery of Novel Covalent Inhibitors of DJ-1 Through Hybrid Virtual Screening	20